Clinical Trial Update: An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms [Phase 4]

View source ↗

Summary

An open-label pharmacokinetic study of vigabatrin in infants with infantile spasms was conducted but later withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

Sponsor: Lundbeck LLC | Conditions: Infantile Spasms | Phase 4 | Status: WITHDRAWN